Pzena Investment Management LLC

Institutional manager·CIK 0001027796
Latest Qtr return
+3.3%
SPY latest qtr
+17.6%
Alpha
-14.2ptsvs SPY
Invested
$30.8B
Holdings
158
Trades YTD
0

Performance · Fund vs SPY

Cumulative return · quarterly snapshots
-5%+0%+75%Pzena +24.6%SPY +72.2%Q1 '25Q2 '25Q3 '25Q4 '25

Coverage 99%. 4 quarters of 2025 measured against SPY adj-close benchmark.

EDITORIAL BRIEF · refreshed Jul 2, 2026

Why follow Pzena Investment Management LLC right now?

Pzena Investment Management LLC reported $30.8B across 158 positions in its Q1 2026 13F-HR (period ending 2026-03-31). The portfolio's largest concentration sits in cyclical and value-oriented names: Magna International leads at 6.4% (25.3M shares), followed by Cognizant at 4.0% and Tyson Foods at 3.6%. Managed care and healthcare feature prominently, with Baxter, Bristol-Myers Squibb, CVS, and Humana collectively representing roughly 13.2% of disclosed holdings.

Notable additions quarter-over-quarter include Marcus & Millichap (+228%), Teleflex (+84%), Accenture (+84%), HDFC Bank (+81%), and Fifth Third Bancorp (+74%). Financials exposure is further reinforced by existing positions in Citigroup and Capital One.

The portfolio returned +3.3% in Q1 2026 against SPY's +17.6%, producing alpha of -14.3% for the quarter. Past performance is not indicative of future results.

Generated from public SEC filings. Not investment advice.…

Read the full 130-word brief. Pro members get the complete editorial analysis on every curated manager, plus Sunday Pulse + Stock Picks.

Unlock with Pro — $9.99/mo

Top holdings · current snapshot

Source: 13F-HR
01
$MGA
MAGNA INTL INC
Q4 2025: Sold 13.0% (29.11M → 25.33M shares)
6.4%
-10.6%
~$77.69 Mar 2026
02
$CTSH
COGNIZANT TECHNOLOGY SOLUTIO
Q4 2025: Increased +14.9% (17.63M → 20.26M shares)
4.0%
-15.1%
~$61.35 Mar 2026
03
$TSN
TYSON FOODS INC
Q4 2025: Increased +12.1% (15.31M → 17.16M shares)
3.6%
-5.7%
~$64.07 Mar 2026
04
$BAX
BAXTER INTL INC
Q4 2025: Sold 7.9% (70.05M → 64.53M shares)
3.5%
+72.1%
~$16.80 Mar 2026
05
$BMY
BRISTOL-MYERS SQUIBB CO
Q4 2025: Sold 4.7% (17.94M → 17.10M shares)
3.4%
+5.5%
~$60.65 Mar 2026
06
$CVS
CVS HEALTH CORP
Q4 2025: Sold 11.6% (15.58M → 13.77M shares)
3.2%
+45.6%
~$71.82 Mar 2026
07
$HUM
HUMANA INC
Q4 2025: Increased +34.4% (4.07M → 5.47M shares)
3.1%
+110.5%
~$173.39 Mar 2026
08
$C
CITIGROUP INC
Q4 2025: Sold 23.0% (10.62M → 8.18M shares)
3.0%
+15.9%
~$113.41 Mar 2026
09
$SWKS
SKYWORKS SOLUTIONS INC
Q4 2025: Increased +27.6% (12.63M → 16.11M shares)
2.8%
+14.8%
~$53.55 Mar 2026
10
$COF
CAPITAL ONE FINL CORP
Q4 2025: Sold 8.8% (5.02M → 4.58M shares)
2.7%
+13.6%
~$182.43 Mar 2026
See all 158 holdings · Pro →

Recent trades · Last 90 days

No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.

Convergence · Pzena Investment Management LLC

Pattern cards reflect public SEC EDGAR and Congressional filing data only. Detection uses filing dates; trade execution dates may differ. Past convergence patterns do not predict future returns. Nothing here is investment advice.

Source data: SEC EDGAR · 13F-HR filings · Performance through 2026-03-31 · Last refreshed 14:38 UTC.